Compile Data Set for Download or QSAR
Report error Found 2270 Enz. Inhib. hit(s) with Target = 'MAP kinase-activated protein kinase 2'
TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  8.80E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515378(US11098061, Compound I-1)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515379(US11098061, Compound I-8)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515380(US11098061, Compound I-3)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515381(US11098061, Compound I-4)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515384(US11098061, Compound I-7)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515385(US11098061, Compound I-9)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515387(US11098061, Compound I-23)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515389(US11098061, Compound II-1)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515390(US11098061, Compound II-2)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515391(US11098061, Compound II-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515392(US11098061, Compound II-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515393(US11098061, Compound II-5)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515394(US11098061, Compound II-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515396(US11098061, Compound II-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515397(US11098061, Compound II-9)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515398(US11098061, Compound II-10)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515399(US11098061, Compound II-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515400(US11098061, Compound II-12)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515401(US11098061, Compound II-13)
Affinity DataEC50:  300nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515402(US11098061, Compound II-14)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515403(US11098061, Compound II-15)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515404(US11098061, Compound II-16)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515414(US11098061, Compound II-26)
Affinity DataEC50:  300nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515415(US11098061, Compound II-27)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515416(US11098061, Compound II-e-1)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515417(US11098061, Compound III-1)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515419(US11098061, Compound III-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515420(US11098061, Compound III-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515421(US11098061, Compound III-5)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515422(US11098061, Compound III-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515423(US11098061, Compound III-7)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515424(US11098061, Compound III-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515426(US11098061, Compound III-10)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515427(US11098061, Compound III-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515428(US11098061, Compound III-12)
Affinity DataEC50:  750nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515429(US11098061, Compound III-13)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515431(US11098061, Compound III-35)
Affinity DataEC50:  300nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515432(US11098061, Compound III-37)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515433(US11098061, Compound III-40)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515436(US11098061, Compound III-45)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515437(US11098061, Compound III-46)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515439(US11098061, Compound IV-2)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515446(US11098061, Compound V-6)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515452(US11098061, Compound V-c-2)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515453(US11098061, Compound V-c-3)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515454(US11098061, Compound V-15)
Affinity DataEC50:  300nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515457(US11098061, Compound II-e-4 | N-(2-(4-methylpipera...)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515458(US11098061, Compound II-e-15)
Affinity DataEC50:  300nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Ambit Biosciences

Curated by PubChem BioAssay
LigandPNGBDBM515459(US11098061, Compound II-e-8 | 2-(4-acryloyl-3,4-di...)
Affinity DataEC50: >1.00E+3nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 2270 total ) | Next | Last >>
Jump to: